US Stocks
/
Acrivon Therapeutics, Inc. Share Price

Acrivon Therapeutics, Inc. Share Price

NASDAQ: ACRV | Micro Cap
$1.87
-$0.01 (-0.53%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Acrivon Therapeutics, Inc. Stock Performance

Open
$1.80
Prev. Close
$1.88
Circuit Range
N/A
Day Range
$1.78 - $1.88
Year Range
$1.27 - $3.54
Volume
21,637
Average Traded
$1.84

Acrivon Therapeutics, Inc. Share Price Today

As of 9 October 2026, Acrivon Therapeutics, Inc.'s share price is $1.87. The stock opened at $1.80, compared to its previous close of $1.88. During today's trading session, Acrivon Therapeutics, Inc.'s share price traded between $1.78 and $1.88, with an average price of $1.83. Over the past 52 weeks, the stock has recorded a high of $3.54 and a low of $1.27. In terms of performance, Acrivon Therapeutics, Inc.'s share price has risen by 1.08% over the last six months and is down 5.56% on a year-on-year basis.

Acrivon Therapeutics, Inc. Share Price Chart

$1.78$1.88
L
Show Current Price
H

Acrivon Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$72.01M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.73
Revenue (TTM)
$0.00
Return On Equity (TTM)
-85.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.48%

Acrivon Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.23-$18.99-$19.04-$17.96
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-4.17%-0.26%5.67%

Acrivon Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$31.17-$60.39-$80.56-$77.91
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-93.74%-33.40%3.29%

About Acrivon Therapeutics, Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Acrivon Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.06
$1.87
-8.78%
Sep 2026
$2.04
$2.05
-5.09%
Aug 2026
$1.49
$2.16
+43.05%
Jul 2026
$1.77
$1.51
-15.17%
Jun 2026
$1.58
$1.78
+10.22%
May 2026
$1.88
$1.61
-12.70%
Apr 2026
$1.46
$1.85
+32.14%
Mar 2026
$1.48
$1.40
-7.59%
Feb 2026
$1.75
$1.51
-15.13%
Jan 2026
$2.39
$1.78
-26.09%
Dec 2025
$2.37
$2.42
+1.90%
Nov 2025
$2.26
$2.37
+19.70%

ACRV Share Price FAQs

What is Acrivon Therapeutics, Inc. share price today?

chevron-up
Acrivon Therapeutics, Inc. share price today is $1.87 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Acrivon Therapeutics, Inc. stock?

chevron-up
The 52 week high of Acrivon Therapeutics, Inc. stock is $3.54, while the 52 week low is $1.27 as of 9 Oct '26.

What is ACRV's market capitalisation today?

chevron-up
ACRV market capitalisation is $72.01M as of October 9, 2026, at 4:48 pm IST.

What is ACRV's net income for the last quarter?

chevron-up
ACRV's net income for the last quarter is -17.96B USD.

What is the 5 year returns of ACRV?

chevron-up
The 5 year returns of ACRV is -85.17% as on 9 Oct '26.

What is the high & low stock price of ACRV today?

chevron-up
ACRV stock price hit a high of $1.88 and low of $1.78 as of 9 Oct '26.

Can I buy ACRV shares in India?

chevron-up
Yes. You can buy ACRV in India by opening an international trading account.